JPMorgan Chase & Co. raised its position in shares of Investors Title (NASDAQ:ITIC - Free Report) by 68.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,497 shares of the insurance provider's stock after acquiring an additional 2,237 shares during the period. JPMorgan Chase & Co. owned approximately 0.29% of Investors Title worth $1,301,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the company. Mountain Hill Investment Partners Corp. bought a new position in Investors Title during the 4th quarter valued at about $47,000. SG Americas Securities LLC raised its holdings in shares of Investors Title by 21.0% in the fourth quarter. SG Americas Securities LLC now owns 616 shares of the insurance provider's stock worth $146,000 after buying an additional 107 shares during the period. Nisa Investment Advisors LLC boosted its holdings in Investors Title by 225.0% during the 4th quarter. Nisa Investment Advisors LLC now owns 650 shares of the insurance provider's stock valued at $154,000 after acquiring an additional 450 shares during the period. Raymond James Financial Inc. purchased a new stake in Investors Title in the fourth quarter worth $222,000. Finally, Trust Co of the South bought a new position in shares of Investors Title in the fourth quarter worth about $322,000. Institutional investors own 41.40% of the company's stock.
Wall Street Analyst Weigh In
Separately, StockNews.com upgraded Investors Title from a "hold" rating to a "buy" rating in a report on Saturday, March 22nd.
Check Out Our Latest Stock Report on ITIC
Investors Title Trading Down 0.2 %
Shares of Investors Title stock traded down $0.44 during trading on Thursday, hitting $230.75. 6,426 shares of the stock traded hands, compared to its average volume of 13,132. Investors Title has a 52-week low of $146.41 and a 52-week high of $290.40. The stock's fifty day simple moving average is $233.33 and its 200 day simple moving average is $240.29. The firm has a market cap of $502.57 million, a P/E ratio of 14.03 and a beta of 0.84.
Investors Title (NASDAQ:ITIC - Get Free Report) last posted its earnings results on Thursday, February 13th. The insurance provider reported $4.41 EPS for the quarter. Investors Title had a net margin of 12.03% and a return on equity of 11.84%. The business had revenue of $70.63 million for the quarter.
Investors Title Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 24th were issued a dividend of $0.46 per share. The ex-dividend date was Monday, March 24th. This represents a $1.84 dividend on an annualized basis and a yield of 0.80%. Investors Title's dividend payout ratio is currently 11.20%.
Investors Title Profile
(
Free Report)
Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.
Further Reading

Before you consider Investors Title, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Investors Title wasn't on the list.
While Investors Title currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.